设为首页         

资讯内容 Content

[AHA2010]降糖药物的心血管安全性——Kausik Ray教授专访
国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

作者:ProfessorKausikRay 编辑:国际循环网 时间:2010/11/17 15:18:01 关键字:低血糖  降糖药物 心力衰竭 K.Ray 


  <International Circulation>:  Are there any agents on the horizon that may give you cause to pause?

  《国际循环》:即将上市的药物中是否有是您犹豫不决的呢?

  Professor Ray: Any drug that works on the incretin pathway appears to have beneficial effects on other factors like weight, for example, resulting in either weight neutrality or weight loss which is a major problem with most hyperglycemic agents we have and at least on lipid profile and maybe on blood pressure there may be slight improvements as well. Because we know the etiology of heart failure is also related to many of the risk factors for atherosclerosis, a combination of those effects may contribute. That doesn’t answer the glucose question though and is more of a strategy, as the drug may have multiple interventions.

    Ray教授:所有通过肠降血糖素途径的药物都对减少体重等其他危险因素有益,例如,目前大部分降糖药都存在导致体重减轻或只能保持体重的问题,对于血脂和血压的改善也微乎其微。我们已经知道心力衰竭的病因与动脉粥样硬化或者某些并存的危险因素有关,药物具有多方面的干预作用。但这并不能解决血糖的问题,它与治疗策略制定的关系更大



上一页  [1]  [2]  [3]  [4]  [5]  下一页

注册

网友评论仅供其表达个人看法,并不表明国际循环同意其观点或证实其描述。 发表评论需登陆

 
关于本站 | 设为首页 | 加入收藏 | 站长邮箱 | 友情链接 | 版权申明

国际循环 版权所有  2008-2024 icirculation.com  All Rights Reserved